• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唾液链球菌经气道递送足以诱导大鼠实验性肺动脉高压。

Airway delivery of Streptococcus salivarius is sufficient to induce experimental pulmonary hypertension in rats.

机构信息

National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangdong Key Laboratory of Vascular Disease, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.

Department of Intensive Care Unit, School of Medicine, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, Guangdong, China.

出版信息

Br J Pharmacol. 2023 Aug;180(16):2102-2119. doi: 10.1111/bph.16064. Epub 2023 Apr 9.

DOI:10.1111/bph.16064
PMID:36869838
Abstract

BACKGROUND AND PURPOSE

The causal relationship between altered host microbiome composition, especially the respiratory tract microbiome, and the occurrence of pulmonary hypertension (PH) has not yet been studied. An increased abundance of airway streptococci is seen in patients with PH compared with healthy individuals. This study aimed to determine the causal link between elevated airway exposure to Streptococcus and PH.

EXPERIMENTAL APPROACH

The dose-, time- and bacterium-specific effects of Streptococcus salivarius (S. salivarius), a selective streptococci, on PH pathogenesis were investigated in a rat model established by intratracheal instillation.

KEY RESULTS

Exposure to S. salivarius successfully induced typical PH characteristics, such as elevated right ventricular systolic pressure (RVSP), right ventricular hypertrophy (Fulton's index) and pulmonary vascular remodelling, in a dose- and time-dependent manner. Moreover, the S. salivarius-induced characteristics were absent in either the inactivated S. salivarius (inactivated bacteria control) treatment group or the Bacillus subtilis (active bacteria control) treatment group. Notably, S. salivarius-induced PH is characterized by elevated inflammatory infiltration in the lungs, in a pattern different from the classic hypoxia-induced PH model. Moreover, in comparison with the SU5416/hypoxia-induced PH model (SuHx-PH), S. salivarius-induced PH causes similar histological changes (pulmonary vascular remodelling) but less severe haemodynamic changes (RVSP, Fulton's index). S. salivarius-induced PH is also associated with altered gut microbiome composition, suggesting potential communication of the lung-gut axis.

CONCLUSION AND IMPLICATIONS

This study provides the first evidence that the delivery of S. salivarius in the respiratory tract could cause experimental PH in rats.

摘要

背景与目的

宿主微生物组组成的改变,尤其是呼吸道微生物组,与肺动脉高压(PH)的发生之间的因果关系尚未得到研究。与健康个体相比,PH 患者的气道链球菌丰度增加。本研究旨在确定气道暴露于链球菌与 PH 之间的因果关系。

实验方法

通过气管内滴注建立大鼠模型,研究了唾液链球菌(S. salivarius),一种选择性链球菌,对 PH 发病机制的剂量、时间和细菌特异性影响。

主要结果

S. salivarius 暴露成功地以剂量和时间依赖的方式诱导出典型的 PH 特征,如右心室收缩压(RVSP)升高、右心室肥厚(富尔顿指数)和肺血管重塑。此外,在灭活 S. salivarius(灭活细菌对照)治疗组或枯草芽孢杆菌(活性细菌对照)治疗组中,均未观察到 S. salivarius 诱导的特征。值得注意的是,S. salivarius 诱导的 PH 以肺部炎症浸润增加为特征,与经典缺氧诱导的 PH 模型不同。此外,与 SU5416/缺氧诱导的 PH 模型(SuHx-PH)相比,S. salivarius 诱导的 PH 引起相似的组织学变化(肺血管重塑)但血流动力学变化较轻(RVSP、富尔顿指数)。S. salivarius 诱导的 PH 也与肠道微生物组组成的改变有关,提示肺-肠轴之间存在潜在的通讯。

结论和意义

本研究首次提供了证据,表明呼吸道中 S. salivarius 的输送可导致大鼠实验性 PH。

相似文献

1
Airway delivery of Streptococcus salivarius is sufficient to induce experimental pulmonary hypertension in rats.唾液链球菌经气道递送足以诱导大鼠实验性肺动脉高压。
Br J Pharmacol. 2023 Aug;180(16):2102-2119. doi: 10.1111/bph.16064. Epub 2023 Apr 9.
2
Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.在实验性肺动脉高压中,非高碳酸血症酸中毒时肺血管反应性改善和肥厚重构减少。
Am J Physiol Lung Cell Mol Physiol. 2012 May 1;302(9):L875-90. doi: 10.1152/ajplung.00293.2011. Epub 2012 Jan 27.
3
SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction.SuHx 大鼠模型:部分可逆性肺动脉高压和进行性内膜阻塞。
Eur Respir J. 2014 Jul;44(1):160-8. doi: 10.1183/09031936.00204813. Epub 2014 May 2.
4
Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling.曲前列尼尔在 SU5416 低氧肺动脉高压模型中的疗效:血流动力学获益与动脉重塑的改善无关。
Br J Pharmacol. 2018 Oct;175(20):3976-3989. doi: 10.1111/bph.14472. Epub 2018 Sep 16.
5
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.抑制 CXCL12 可减轻大鼠已形成的肺动脉高压。
Cardiovasc Res. 2020 Mar 1;116(3):686-697. doi: 10.1093/cvr/cvz153.
6
Research on rat models of hypobaric hypoxia-induced pulmonary hypertension.低压缺氧诱导肺动脉高压大鼠模型的研究
Eur Rev Med Pharmacol Sci. 2015 Oct;19(19):3723-30.
7
Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertension.肠道-肺部轴心在肺动脉高压中的微生物组和代谢组失调。
Microbiol Res. 2022 Dec;265:127205. doi: 10.1016/j.micres.2022.127205. Epub 2022 Sep 21.
8
Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416/hypoxia rat model.肠道微生物群修饰可抑制SU5416/低氧大鼠模型中肺动脉高压的发展。
Pulm Circ. 2020 Aug 27;10(3):2045894020929147. doi: 10.1177/2045894020929147. eCollection 2020 Jul-Sep.
9
Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.肺动脉血管收缩功能受损和一氧化氮介导的舒张功能障碍导致 Sugen 缺氧大鼠模型中的严重肺动脉高压。
J Pharmacol Exp Ther. 2018 Feb;364(2):258-274. doi: 10.1124/jpet.117.244798. Epub 2017 Dec 6.
10
C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade.C 型利钠肽不能减轻缺氧和血管内皮生长因子受体阻断引起的肺动脉高压的发展。
Life Sci. 2011 Sep 26;89(13-14):460-6. doi: 10.1016/j.lfs.2011.07.009. Epub 2011 Jul 27.

引用本文的文献

1
Dysbiosis associated with enhanced microbial mobility across the respiratory tract in pulmonary tuberculosis patients.与肺结核患者呼吸道微生物移动性增强相关的生态失调。
BMC Microbiol. 2025 Aug 12;25(1):499. doi: 10.1186/s12866-025-04206-x.
2
Gut Microbiome in Pulmonary Arterial Hypertension-An Emerging Frontier.肺动脉高压中的肠道微生物群——一个新兴前沿领域。
Infect Dis Rep. 2025 Jun 9;17(3):66. doi: 10.3390/idr17030066.
3
Distinct airway mycobiome signature in patients with pulmonary hypertension and subgroups.肺动脉高压患者及其亚组中独特的气道真菌微生物群特征
BMC Med. 2025 Mar 10;23(1):148. doi: 10.1186/s12916-025-03982-7.
4
Promising dawn in the management of pulmonary hypertension: The mystery veil of gut microbiota.肺动脉高压治疗的希望曙光:肠道微生物群的神秘面纱。
Imeta. 2024 Jan 1;3(2):e159. doi: 10.1002/imt2.159. eCollection 2024 Apr.
5
Human genetic associations of the airway microbiome in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者气道微生物组的人类遗传相关性研究。
Respir Res. 2024 Apr 16;25(1):165. doi: 10.1186/s12931-024-02805-2.
6
Periodontitis exacerbates pulmonary hypertension by promoting IFNγ T cell infiltration in mice.牙周炎通过促进 IFNγ T 细胞浸润加剧小鼠肺动脉高压。
Int J Oral Sci. 2024 Mar 28;16(1):27. doi: 10.1038/s41368-024-00291-2.